Chaykovska Lyubov, Deger Serdar, Wille Andreas, Friedersdorff Frank, Kasper Antje, Dragun Duska, Liefeldt Lutz, Miller Kurt, Giessing Markus, Fuller T Florian
Department of Urology, Charité University Hospital Campus Mitte, Berlin, Germany.
Urology. 2009 Feb;73(2):380-5. doi: 10.1016/j.urology.2008.07.069. Epub 2008 Nov 20.
To evaluate the functional outcomes and complications after allogeneic kidney transplantation into recipients with a urinary conduit using ureteroureterostomy between the transplant and native ureter.
We performed a retrospective study of 6 patients with a pre-existing urinary conduit undergoing kidney transplantation at a single tertiary academic center from May 1982 to February 2007.
The study included 1 female and 5 males aged 16 to 65 years. Two patients received a living donor transplant. The indications for pretransplant conduit formation were neurogenic bladder in 3 and bladder contraction with vesicoureteral reflux in 3. One patient received a colon conduit. All patients underwent kidney transplantation into a urinary conduit using ureteroureterostomy between the transplant ureter and the ipsilateral native ureter. The average interval between conduit formation and kidney transplantation was 83.5 months and the average time of requiring hemodialysis was 56.3 months. The mean follow-up was 5.3 years. The patient and graft survival rate was 100% and 83.3%, respectively. The 3-year serum creatinine averaged 1.4 mg/dL. One graft was lost because of chronic rejection. Transplant ureter obstruction occurred in 2 patients and required endoscopy or open revision. Four patients underwent post-transplant native nephrectomy for recurrent pyelonephritis. Three patients were hospitalized for treatment of graft pyelonephritis.
In our experience, ureteroureterostomy between the transplant and native ureter is technically feasible and provides good functional results despite a high incidence of urinary tract infection. We recommend this approach in renal transplant recipients with a short contracted conduit or in those in whom the donor ureter is too short to warrant a tension-free ureteroileal anastomosis.
评估在接受输尿管-输尿管吻合术将异体肾移植到已有尿流改道受者体内后,移植肾的功能结局及并发症情况。
我们对1982年5月至2007年2月在一家三级学术中心接受肾移植的6例已有尿流改道的患者进行了回顾性研究。
该研究包括1名女性和5名男性,年龄在16至65岁之间。2例患者接受了活体供肾移植。移植前形成尿流改道的指征为3例神经源性膀胱和3例膀胱挛缩伴膀胱输尿管反流。1例患者接受了结肠造瘘。所有患者均接受了输尿管-输尿管吻合术,将移植肾输尿管与同侧自体输尿管吻合,移植到尿流改道患者体内。尿流改道形成与肾移植之间的平均间隔时间为83.5个月,平均需要血液透析的时间为56.3个月。平均随访时间为5.3年。患者和移植肾的生存率分别为100%和83.3%。3年时血清肌酐平均为1.4mg/dL。1例移植肾因慢性排斥反应而丢失。2例患者发生移植肾输尿管梗阻,需要进行内镜检查或开放修复。4例患者因复发性肾盂肾炎接受了移植后自体肾切除术。3例患者因移植肾肾盂肾炎住院治疗。
根据我们的经验,移植肾输尿管与自体输尿管之间的输尿管-输尿管吻合术在技术上是可行的,尽管尿路感染发生率较高,但仍能提供良好的功能结果。我们建议在输尿管短缩或供体输尿管过短无法进行无张力输尿管-回肠吻合的肾移植受者中采用这种方法。